Can a patient with an infected arteriovenous fistula (AVF) undergoing treatment with intravenous (IV) antibiotics still undergo dialysis through the infected AVF?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient with an Infected AVF Continue Dialysis Through That Access?

Yes, a patient with an infected arteriovenous fistula (AVF) can continue dialysis through the infected access while receiving IV antibiotics, but cannulation must avoid the infected site itself. 1

Treatment Protocol for Infected AVF

Primary Management Strategy

  • Infected AVFs are rare and should be treated as subacute bacterial endocarditis with 6 weeks of IV antibiotic therapy. 1
  • Initial empiric antibiotic coverage must include both Gram-negative and Gram-positive organisms, including Enterococcus, until culture results guide definitive therapy. 1
  • The infected AVF can remain in use for dialysis during antibiotic treatment, unlike infected grafts which often require surgical intervention. 1

Critical Cannulation Restrictions

  • Cannulation must cease at the specific infected site—needles should be placed in unaffected portions of the fistula away from any area showing signs of infection. 2
  • Avoid cannulating through or near sites with erythema, warmth, tenderness, drainage, or compromised skin integrity. 3, 2
  • The "Look-Listen-Feel" approach should be performed before each dialysis session to identify safe cannulation zones. 2

When AVF Takedown Is Required

  • Fistula takedown (surgical removal) is mandatory only in cases of septic emboli. 1
  • Immediate AVF closure is also required for monomelic ischemic neuropathy or severe symptomatic ischemia with tissue necrosis. 2
  • If the patient remains symptomatic with fever/bacteremia for more than 36 hours despite appropriate antibiotics, or if the patient is clinically unstable, surgical intervention should be considered. 1

Key Distinction: AVF vs. AVG Infections

AVF (Native Fistula) Infections

  • Can typically be salvaged with antibiotics alone (6-week course). 1
  • Surgical repair is effective in 82% of cases when needed, preserving the native access. 4
  • Dialysis can continue through unaffected portions during treatment. 1

AVG (Synthetic Graft) Infections

  • Local infection requires antibiotics PLUS incision/resection of the infected graft portion. 1
  • Extensive infection requires antibiotics AND total graft resection. 1
  • Newly placed grafts (within 1 month) require complete removal regardless of infection extent. 1

Alternative Access Considerations

  • If the infected AVF cannot be safely cannulated due to extensive involvement, establish temporary alternative access (tunneled catheter, not PICC line) rather than abandoning the fistula. 1, 5
  • Avoid PICC lines in dialysis patients as they are associated with 2.8-fold increased odds of AVF failure (OR 2.8,95% CI 1.5-5.5). 5
  • If parenteral antibiotics require central access, use a tunneled central venous catheter rather than a PICC to preserve peripheral veins. 5

Monitoring During Treatment

  • Assess the access at every dialysis session for changes in thrill, bruit, or new signs of infection spread. 2
  • Monitor for systemic signs: persistent fever, chills, or bacteremia beyond 36 hours warrant reassessment of the treatment plan. 1
  • Blood cultures should be repeated periodically during and immediately after antibiotic therapy. 1
  • Resume full use of the AVF only when infection has completely resolved, swelling has substantially subsided, and the entire access course is easily palpable. 3

Common Pitfalls to Avoid

  • Do not delay evaluation or treatment—even minor signs of AVF infection require immediate initiation of the 6-week antibiotic protocol. 1, 2
  • Do not attempt to cannulate through infected tissue, as this exacerbates the infection and risks access failure. 3, 2
  • Do not confuse AVF management with AVG management—infected grafts almost always require surgical intervention, while infected fistulas can usually be salvaged medically. 1, 4
  • Failing to recognize early signs of septic emboli (new neurologic deficits, peripheral embolic phenomena) delays necessary surgical takedown. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Arteriovenous Fistula Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Clear Liquid Leakage from AV Fistula Graft Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Selection for CKD Patients After AVF Creation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Can a peripheral line near an Arteriovenous Fistula (AVF) be used for intravenous (IV) antibiotic infusion via heplock in dialysis patients?
Can intravenous (IV) antibiotics be administered through dialysis access?
Can an arterial sample be obtained from the same arm where an arteriovenous fistula (AVF) for dialysis is located?
Are hypoechoic tracts leading to the urinary bladder a risk for developing a fistula?
Are antibiotics needed before a dilation and curettage (D&C)?
When is platelet transfusion recommended in patients with spontaneous bleeding and thrombocytopenia (low platelet count)?
What is the best approach for a female patient with a history of myelodysplastic syndrome or possible acute leukemia, who presents with spontaneous gingivoral bleeding and headaches, and has thrombocytopenia?
What is the recommended treatment plan for a patient with advanced osteoarthritis and potential labral tear of the right hip, characterized by femoral-acetabular dysplasia, CAM (Cervical-Acetabular Morphology) lesion, and degenerative changes in the acetabular cartilage, with minimal synovitis and joint fluid, and no evidence of acute fracture, subluxation, or avascular necrosis?
What medications or supplements are affected in a patient with a CYP2D6 (cytochrome P450 2D6) variation?
What is the treatment for disseminated intravascular coagulation (DIC) in a patient who developed it after chemotherapy?
Will I regain mobility in my wrist and fingers, given that I have wrist drop (radial nerve palsy) but can perform finger tasks with ease when my wrist is supported, and I've noticed improvement in my middle finger over time?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.